Fas ligand-induced apoptosis

被引:636
作者
Nagata, S [1 ]
机构
[1] Osaka Med Sch, Dept Genet, Osaka, Japan
[2] Japan Sci & Technol Corp, Osaka 5650871, Japan
关键词
cell death; Fas; death factor; cytotoxic T lymphocytes; lymphoproliferation;
D O I
10.1146/annurev.genet.33.1.29
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The immune response is regulated not only by cell proliferation and differentiation, but also by programmed cell death, or apoptosis. in response to various stimuli, death factors bind to their respective receptors and activate the apoptotic death program in target cells. A cascade of specific proteases termed caspases mediates the apoptotic process. The activated caspases cleave various cellular components, a process that leads to morphological changes of the cells and nuclei, as well as to degradation of the chromosomal DNA. Loss-of-function mutations in the signaling molecules involved in apoptosis cause hyper-proliferation of cells in mouse and human. In contrast, exaggeration of this death cascade causes the destruction of various tissues.
引用
收藏
页码:29 / 55
页数:27
相关论文
共 195 条
[51]  
GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104
[52]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[53]  
Gronbaek K, 1998, BLOOD, V92, P3018
[54]   FAS-INDUCED APOPTOSIS IS MEDIATED VIA A CERAMIDE-INITIATED RAS SIGNALING PATHWAY [J].
GULBINS, E ;
BISSONNETTE, R ;
MAHBOUBI, A ;
MARTIN, S ;
NISHIOKA, W ;
BRUNNER, T ;
BAIER, G ;
BAIERBITTERLICH, G ;
BYRD, C ;
LANG, F ;
KOLESNICK, R ;
ALTMAN, A ;
GREEN, D .
IMMUNITY, 1995, 2 (04) :341-351
[55]   Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366
[56]   Differential requirement for Caspase 9 in apoptotic pathways in vivo [J].
Hakem, R ;
Hakem, A ;
Duncan, GS ;
Henderson, JT ;
Woo, M ;
Soengas, MS ;
Elia, A ;
de la Pompa, JL ;
Kagi, D ;
Khoo, W ;
Potter, J ;
Yoshida, R ;
Kaufman, SA ;
Lowe, SW ;
Penninger, JM ;
Mak, TW .
CELL, 1998, 94 (03) :339-352
[57]   Functions of ceramide in coordinating cellular responses to stress [J].
Hannun, YA .
SCIENCE, 1996, 274 (5294) :1855-1859
[58]   Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia [J].
Hasegawa, D ;
Kojima, S ;
Tatsumi, E ;
Hayakawa, A ;
Kosaka, Y ;
Nakamura, H ;
Sako, M ;
Osugi, Y ;
Nagata, S ;
Sano, K .
BLOOD, 1998, 91 (08) :2793-2799
[59]   Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies [J].
Hattori, K ;
Hirano, T ;
Miyajima, H ;
Yamakawa, N ;
Tateno, M ;
Oshimi, K ;
Kayagaki, N ;
Yagita, H ;
Okumura, K .
BLOOD, 1998, 91 (11) :4051-4055
[60]   DIMERIZATION OF CELL-SURFACE RECEPTORS IN SIGNAL-TRANSDUCTION [J].
HELDIN, CH .
CELL, 1995, 80 (02) :213-223